Novavax—a biotechnology company located in Gaithersburg—has been awarded $1.6 billion to accelerate the development of a potential COVID-19 vaccine. The company announced Tuesday that it has been selected to participate in Operation Warp Speed. This federal government program will help cover testing, commercialization, and manufacturing of a potential COVID-19 vaccine in the United States. The program […]
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia